| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |